**Core tip:** Cirrhosis mortality varies across hospitals, but it is not well-understood what differences between hospitals contribute to this variation. In our study, using administrative data on cirrhosis discharges and a national dataset on hospital structural characteristics, we found that several hospital factors including payer-mix and staffing patterns were associated with risk-adjusted mortality, but hospital experience with cirrhosis and presence of a liver transplant program were associated with survival. Structural factors are vital components to cirrhosis care delivery, and account for a significant proportion of the variation in cirrhosis mortality observed between hospitals. Future research should focus on other areas of variation, including differences in processes of cirrhosis care.

INTRODUCTION
============

Cirrhosis is the final common pathway for chronic liver disease, which predisposes patients to life-threatening complications. These complications - including ascites, spontaneous bacterial peritonitis, hepatic hydrothorax, variceal hemorrhage, hepatic encephalopathy, and hepatocellular carcinoma - require significant inpatient resources for appropriate and timely management to ensure good clinical outcomes\[[@B1]\]. Inpatient admissions for cirrhosis represent a critical juncture in the con tinuum of care of liver disease, because hospitals differ in their ability to care for these patients. We have previously demonstrated that hospitals differ 14-fold in mortality rates for cirrhosis\[[@B1]\], but the mechanism behind these differences is relatively unknown.

A major impediment to improving mortality in cirrhosis is a lack of national-level clinical registry data, which obligates providers to utilizing inferential studies from a variety of data sources to change practices\[[@B1]\]. Conceptually, variation in cirrhosis mortality between hospitals, using the Donabedian model of health care quality, are attributable to differences in: (1) patient characteristics and severity of disease; (2) the structure of health care facilities; and (3) processes of cirrhosis care\[[@B1]\]. Two hospitals can only have different clinical outcomes if they differ in these factors. Processes of care are the way in which care is delivered in a particular context and how prevailing structural resources are used for patients. These are of critical importance, but cirrhosis quality measures are not tracked nationally\[[@B1]\]. However, facility resources create the context for these processes, and are easily measured. For inpatient cirrhosis care, these resources include hospital bed capacity, staffing patterns of physicians and nurses, teaching status, endoscopic and imaging services, critical care and transplant personnel, and other specialized services.

In this study, we aimed to further evaluate the mechanism behind hospital variation in cirrhosis mortality by evaluating structural differences while controlling for patient differences. Specifically, we aimed to identify specific factors that were different between hospitals based on their risk-adjusted performance, whether these factors were associated with survival, and to what extent did they explain variation in cirrhosis mortality across hospitals. This approach would therefore allow us to "partition the total variance" in cirrhosis outcomes among patient differences, which are largely immutable, and modifiable factors such as hospital resource intensity, and, by exclusion, processes of care.

MATERIALS AND METHODS
=====================

Data sources
------------

We captured admissions from the Nationwide Inpatient Sample (NIS) from the years 2005-2011. The NIS is the largest publicly available inpatient care database in the United States. It is sponsored by the Agency for Healthcare Research and Quality (AHRQ) through the Healthcare Cost and Utilization Project (HCUP). It contains clinical and resource utilization information for over 7 million admissions per year from a stratified sample of 20% of discharges from US acute care hospitals. Facility characteristics were derived from the American Hospital Association (AHA) Annual Survey. This survey contains data on approximately 6500 hospitals nationwide with over 1000 elements covering hospital facilities, services, organization, and personnel. We merged NIS and AHA data using a common hospital identifier for each cirrhosis admission in each year.

Admission selection
-------------------

We utilized admissions from NIS that contained an AHA Annual Survey identifier and had corresponding data in the AHA Survey. We captured cirrhotic admissions as previously described\[[@B1],[@B2]\]. Briefly, we included admissions with a primary or secondary diagnosis of cirrhosis (alcoholic, non-alcoholic, or biliary) or a complication of cirrhosis (ascites, hepatic encephalopathy, hepatorenal syndrome, portal hypertension, or variceal bleed). We excluded admissions to hospitals with a cirrhotic volume less than 25 patients annually as well as admissions missing data on sex, insurance type, hospital bed size, or had inconsistent or undefined liver transplant program status across the study period\[[@B1],[@B2]\].

Statistical analysis
--------------------

We first created a risk and reliability-adjusted logistic regression model for mortality for any given hospital compared to an average hospital. We did this by first creating a hierarchical logistic regression model where patient covariates and year of admission were treated as fixed effects (level 1 variables) and hospital (level 2 variables) was treated as a random effect. Patient covariates included age, sex, race/ethnicity, cause of cirrhosis including hepatitis C virus positivity, alcoholic liver disease, or other, and presence of cirrhotic complications including ascites, variceal bleed, hepatic encephalopathy, portal hypertension, hepatorenal syndrome, liver transplant, hepatocellular carcinoma, requirement of paracentesis or esophagogastroduodenoscopy. Further adjustment for clinical co-morbidities was included in the model using the all patient refined-diagnosed related group (APR-DRG) risk of mortality\[[@B2],[@B3]\].

Using this model, we then used the empirical Bayes technique to estimate a risk and reliability adjusted odds ratio for mortality via the random effects estimate\[[@B4],[@B5]\]. Of note, this method is considered to be a relatively conservative one, as it "shrinks" variation towards the mean. This estimate incorporated the above fixed effects for risk adjustment and the hospital cirrhosis volume to adjust for reliability of the mortality measurement. We then partitioned hospital into quintiles based on the adjusted OR for mortality (quintile 1 included highest performing hospitals (lowest adjusted OR's for mortality) and quintile 5 included lowest performing (highest adjusted OR's for mortality).

We subsequently examined whether patient covariates and key hospital characteristics varied across quintiles. Hospital characteristics representing several structural domains including organizational structure, personnel, hospital facilities and services, and financial performance were selected based on previous literature\[[@B6]\] and included liver transplant program status, cirrhosis volume, the number of ICU beds, teaching status (number of resident full-time equivalents), and payer mix (the number of yearly Medicaid days), clinical staffing (licensed practical nurses (LPNs), and physicians per adjusted facility patient days). These structural variables were based on previous studies on the role of hospital structure on clinical outcomes\[[@B6]\], but were further expanded to include clinical resources specifically relevant to the management of cirrhotic patients.

We designed the statistical models to conceptually understand what factors account for differences in the mortality rate (risk and reliability-adjusted) between hospitals. Specifically, we assumed that variance in mortality was attributable to (1) clinical differences between patients; (2) hospital differences (further delineated by differences in structural variables); and (3) unmeasured factors (differences in unmeasured processes of care, other factors, and random error. We created a cumulative hierarchical logistic regression model that added these structural variables sequentially to calculate the fraction of inter-hospital variance in adjusted mortality explained by each structural variable. The baseline model adjusted for clinical differences between patients, and we evaluated the change in the calculated variance of the model with the sequential addition of specific structural characteristics. These were selected from the factors significantly different across mortality quintiles on univariate analysis. This approach assumed that structural factors contribute to variation in mortality between hospitals, and adjusting for them would attenuate the measured variance, *i.e*., more of the differences between hospitals would be explained by the model as more significant structural factors were included.

These data were publicly available administrative data and were exempt from Institutional Review Board approval at the University of Michigan. All statistical analyses were performed using Stata 13 (Stata Corp, College Station, TX, United States). Statistical significance was considered at the *P* = 0.05 level.

RESULTS
=======

Figure [1](#F1){ref-type="fig"} demonstrates the range of risk and reliability-adjusted odds ratios (aOR) for in-hospital mortality, or hospital performance in cirrhosis. The demographic characteristics of the study cohort are included in Table [1](#T1){ref-type="table"} and stratified by aOR quintiles. The study cohort included 72733 hospital admissions from 2005-2011 that were divided amongst 805 hospitals. 29.6% of hospitalizations occurred in the lowest-mortality 20% of hospitals, and 20.6% of hospitalizations occurred in the highest-mortality 20%. Patient demographic distributions varied significantly across quintiles, including age, sex, race, and payer mix. The mean age of the cohort was 57.2 years and was nearly 65% male. White patients had a higher proportion of admissions in the lowest-mortality hospitals, and minority race patients had higher relative proportions in the highest-mortality hospitals. Insurance status also varied significantly - the lowest performing hospitals had the highest relative proportions of government-paid admissions and the lowest proportions of privately insured patients. Differences in causes of cirrhosis were statistically significant, but absolute differences were quite small from a clinical standpoint. From a case mix perspective, the lowest performing hospitals had a greater proportion of the relatively lower risk patients (APR-DRG minor and moderate), whereas the highest performing hospitals had a greater proportion of the highest mortality risk patients (APR-DRG major and extreme). Within quintiles, the mean crude mortality rate ranged from 5.1%-12.3%.

###### 

Patient and hospital characteristics by hospital performance quintile in risk and reliability-adjusted cirrhosis mortality

                                                            **Q1 (highest performance)**   **Q2**   **Q3**   **Q4**   **Q5 (lowest performance)**   **Overall**   ***P* value**
  --------------------------------------------------------- ------------------------------ -------- -------- -------- ----------------------------- ------------- ---------------
  Patient characteristics                                                                                                                                         
  Patients                                                  21524                          11117    12427    12648    15017                         72733         \-
  Demographics                                                                                                                                                    
  Age                                                                                                                                                             
  Mean age (yr)                                             56.8                           57.5     57.6     57.3     57.4                          57.2          \< 0.00001
  Sex                                                                                                                                                             
  Female (%)                                                36.4                           36.7     35.9     35.0     35.3                          35.9          0.01381
  Race                                                                                                                                                            
  White (%)                                                 59.9                           55.6     54.8     51.7     52.6                          55.4          \< 0.00001
  Black (%)                                                 5.8                            7.7      5.6      5.7      9.0                           6.7           
  Hispanic (%)                                              15.2                           20.2     21.5     17.4     20.3                          18.5          
  Asian or Pacific Islander (%)                             1.6                            1.8      2.3      1.3      2.2                           1.8           
  Native American (%)                                       1.6                            0.5      0.8      1.1      0.9                           1.1           
  Other (%)                                                 1.6                            2.0      2.6      3.3      3.1                           2.4           
  Missing (%)                                               14.4                           12.1     12.4     19.6     12.0                          14.1          
  Insurance                                                                                                                                                       
  Medicare (%)                                              36.1                           37.2     38.0     36.9     37.3                          37.0          \< 0.00001
  Medicaid (%)                                              22.9                           24.5     24.8     23.8     26.5                          24.4          
  Private Insurance (%)                                     27.4                           26.5     25.2     25.3     22.5                          25.5          
  Self-Pay (%)                                              7.5                            7.4      7.3      8.4      7.8                           7.7           
  No Charge (%)                                             1.0                            0.4      0.6      0.5      1.5                           0.9           
  Other (%)                                                 5.0                            4.0      4.0      5.0      4.3                           4.6           
  Cause of cirrhosis[1](#T1FN1){ref-type="table-fn"}                                                                                                              
  Alcoholic liver disease (%)                               61.0                           62.5     61.0     60.8     60.3                          61.1          0.00880
  Alcoholic cirrhosis (%)                                   60.9                           62.4     60.9     60.6     60.2                          60.9          0.00589
  Non-alcoholic cirrhosis (%)                               38.0                           36.9     38.0     38.6     39.0                          38.1          0.00762
  Biliary cirrhosis (%)                                     2.3                            1.5      2.0      1.7      1.6                           1.9           \< 0.00001
  HCV positive (%)                                          25.3                           23.0     22.1     25.1     26.4                          24.6          \< 0.00001
  Unspecified liver disease or cirrhosis (%)                2.7                            2.0      2.0      2.0      1.8                           2.2           \< 0.00001
  A1AT, Cu, Fe disease (%)                                  0.89                           0.65     0.64     0.74     0.68                          0.74          0.04067
  Complications of Cirrhosis                                                                                                                                      
  Ascites (%)                                               31.8                           27.5     30.2     30.3     26.9                          29.6          \< 0.00001
  Variceal bleed (%)                                        9.6                            10.3     9.6      9.3      9.4                           9.6           0.05605
  Hepatic Encephalopathy (%)                                53.7                           55.2     52.5     54.1     55.7                          54.2          \< 0.00001
  Portal HTN (%)                                            44.3                           41.1     44.9     42.7     41.5                          43.0          \< 0.00001
  Hepatorenal syndrome (%)                                  9.3                            7.8      8.2      8.3      8.9                           8.6           0.00003
  Hepatocellular carcinoma (%)                              3.9                            2.7      3.1      3.1      3.2                           3.3           \< 0.00001
  Procedures                                                                                                                                                      
  Liver transplant                                          2.7                            0.6      1.0      1.1      2.4                           1.7           \< 0.00001
  Esophagogastroduodenoscopy                                18.1                           19.0     20.4     19.3     18.3                          18.9          \< 0.00001
  Paracentesis                                              32.9                           29.7     30.0     29.7     29.2                          30.6          \< 0.00001
  Mortality characteristics                                                                                                                                       
  APR-DRG Risk of Mortality                                                                                                                                       
  Minor risk of mortality (%)                               5.9                            7.8      6.8      6.5      9.1                           7.1           \< 0.00001
  Moderate risk of mortality (%)                            31.3                           34.1     34.4     33.2     34.0                          33.2          
  Major risk of mortality (%)                               41.0                           39.4     39.4     39.5     37.0                          39.4          
  Extreme risk of mortality (%)                             21.8                           18.7     19.4     20.7     19.9                          20.3          
  Mortality                                                                                                                                                       
  Expired during admission (%)                              5.1                            6.0      7.5      9.8      12.3                          7.9           \< 0.00001
  Hospital characteristic                                                                                                                                         
  Number of hospitals                                       161                            161      161      161      161                           805           \-
  Region                                                                                                                                                          
  Northeast hospital region (%)                             19.3                           25.5     27.3     24.8     34.2                          26.2          0.06961
  Midwest hospital region (%)                               18.6                           13.7     17.4     13.0     9.3                           14.4          
  South hospital region (%)                                 29.2                           32.3     19.9     29.2     26.7                          27.5          
  West hospital region (%)                                  32.9                           28.6     35.4     32.9     29.8                          31.9          
  Bed capacity                                                                                                                                                    
  Small bedsize (%)                                         23.0                           41.0     36.6     33.5     32.3                          33.3          0.05554
  Medium bedsize (%)                                        37.9                           31.7     32.9     34.2     29.8                          33.3          
  Large bedsize (%)                                         39.1                           27.3     30.4     32.3     37.9                          33.4          
  Hospital ICU beds (mean)                                  24.3                           19.1     20.1     19.9     20.8                          20.8          0.04608
  Patient casemix                                                                                                                                                 
  Hospital Cirrhosis Annual Volume (mean)                   133.7                          69.0     77.2     78.6     93.3                          90.4          \< 0.00001
  Medicaid Days (mean)                                      18139                          15339    18158    18699    22662                         18599         0.18260
  Admission characteristics                                                                                                                                       
  Length of stay (days) (mean)                              5.9                            5.7      5.9      6.2      6.4                           6.0           0.00019
  Total charges (\$ mean)[2](#T1FN2){ref-type="table-fn"}   43391                          36593    40500    43389    40340                         40877         0.19458
  Expired during admission (%)                              4.0                            5.3      7.3      10.1     13.2                          8.0           \< 0.00001
  Staffing characteristics                                                                                                                                        
  Full-time LPN's[3](#T1FN3){ref-type="table-fn"} (mean)    1.65                           2.18     2.18     1.94     2.34                          2.06          0.03218
  Full-time MD's[3](#T1FN3){ref-type="table-fn"} (mean)     2.74                           2.02     2.55     1.88     1.8                           2.2           0.27122
  Teaching Status                                                                                                                                                 
  Teaching hospital[4](#T1FN4){ref-type="table-fn"} (%)     42.9                           32.9     38.5     39.8     41.6                          39.1          0.40386
  Resident FTE's (mean)                                     79.2                           40.7     57.7     59.0     65.7                          60.5          0.33158
  Specialty Services                                                                                                                                              
  Liver transplant hospital (%)                             15.5                           5.0      5.0      5.6      4.3                           7.1           0.00020

Patients have multiple diagnoses;

19 hospitals missing total charge data on 1751 patients;

per 10000 Adjusted Patient days;

43 hospitals that changed teaching status during the study period were considered teaching if 50% or more of patients were admitted while a teaching hospital.

![Variation in risk and reliability-adjusted mortality for cirrhosis admissions. The 805 hospitals in the analysis demonstrated tremendously variable mortality risk, even after risk adjusting for clinical and demographic differences between patients and accounting for differences in the reliability of the estimate for a given hospital, which is driven by institutional cirrhosis volume. Cirrhosis mortality odds ratios ranged from nearly 50% lower than the average hospital to 200% higher for some hospitals.](WJG-23-1857-g001){#F1}

Facility characteristics differed by hospital performance quintile in cirrhosis on univariate analysis (Table [1](#T1){ref-type="table"}). Cirrhosis volume had a U-shaped distribution when distributed across mortality quintiles - the highest and lowest performing quintiles had an average of 20.8%-73.2% more cirrhosis admissions compared to the average performing hospitals (Table [1](#T1){ref-type="table"}). The lowest quintile had nearly 25% greater Medicaid case-mix than the other groups. There were no significant differences in total bed capacity, but ICU bed capacity was roughly 20% larger in the highest quintile compared to the other groups. Staffing patterns were significantly different as well. Nurse staffing with LPNs was 40% greater in low performing hospitals compared to the highest quintile, however physician staffing was similar. 15.5% of the highest performing hospitals were liver transplant centers, which was three-fold greater than average or low performing hospitals. While not statistically significant, the geographic make-up of each performance quintile was also asymmetric. The highest performing group had more Western and Midwestern hospitals, and less Northeastern and Southern hospitals. This distribution was reversed in the lowest performing group - Northeastern hospitals made up more than 34% of this group.

In a multivariable risk-adjusted model evaluating predictors of cirrhosis mortality, both patient and facility factors were significant (Table [2](#T2){ref-type="table"}). At the patient level, individual cirrhosis complications and co-morbidities were significant predictors of mortality - clinical presentation of hemorrhage, documented portal hypertension, hepatitis C status, alcoholic liver disease, and APR-DRG risk score were significant predictors of mortality (all, *P* ≤ 0.005). Invasive diagnostic and therapeutic procedures including endoscopy, paracentesis, and liver transplantation were significantly protective (all, *P* \< 0.01). There was also a significant era effect, as each successive year was independently associated with lower mortality (all, *P* \< 0.001). At the facility level, each additional cirrhosis admission was associated with 0.05% lower odds of mortality. Liver transplant centers had 17% lower odds of mortality non-transplant facilities across all cirrhosis admissions. Medicaid payer-mix and more LPN nurse staffing were also associated with higher mortality.

###### 

Risk-adjusted effects of patient factors, era, and hospital resources on in-patient cirrhosis mortality

  **Characteristic**                                 **OR**      **95%CI**   ***P* value**
  -------------------------------------------------- ----------- ----------- ---------------
  Patient covariates                                                         
  Age                                                1.00        0.97-1.01   0.592
  Female                                             1.05        0.93-1.06   0.753
  Ascites                                            1.79        0.96-1.15   0.262
  Variceal hemorrhage                                1.26        1.64-1.95   \< 0.001
  Hepatic encephalopathy                             0.63        1.18-1.34   \< 0.001
  Portal hypertension                                1.16        0.59-0.68   \< 0.001
  Hepatorenal syndrome                               0.20        1.07-1.25   \< 0.001
  Received liver transplant                          0.83        0.15-0.26   \< 0.001
  HCV positive                                       1.43        1.33-1.54   \< 0.001
  Alcoholic liver disease                            1.23        1.33-1.54   \< 0.001
  Paracentesis during admission                      0.76        0.71-0.82   0.006
  EGD during admission                               0.81        0.75-0.88   \< 0.001
  Co-morbidity burden (APR DRG risk of mortality)                            
  Minor                                              Reference               
  Moderate                                           1.54        1.14-2.07   0.005
  Major                                              6.02        4.55-7.96   \< 0.001
  Extreme                                            58.8        44.5-77.8   \< 0.001
  Era (year of admission)                                                    
  2005                                               Reference               
  2006                                               0.89        0.79-1.00   0.053
  2007                                               0.79        0.70-0.89   \< 0.001
  2008                                               0.75        0.66-0.85   \< 0.001
  2009                                               0.68        0.60-0.78   \< 0.001
  2010                                               0.51        0.56-0.59   \< 0.001
  2011                                               0.49        0.42-0.56   \< 0.001
  Hospital resources (hospital structural factors)                           
  Hospital cirrhosis volume                          1.01        1.00-1.01   0.025
  Hospital medicaid days                             1.01        1.00-1.01   0.029
  Hospital liver transplant program                  0.83        0.71-0.98   0.026
  Full-time LPN's                                    1.02        1.00-1.04   0.015
  Full-time MD's                                     0.99        0.98-1.00   0.140
  Resident FTE's                                     1.00        1.00-1.00   0.115
  ICU beds                                           1.00        1.00-1.00   0.446

To better understand the magnitude of between-hospital variation in cirrhosis mortality further, we evaluated how individual facility characteristics cumulatively affected measured mortality (Figure [2](#F2){ref-type="fig"}). With the cumulative effect of all structural variables added into the model, overall, 15.3% of the total variation is related to these parameters. The remaining variation remains unmeasured.

![Inter-hospital variation in cirrhosis mortality explained by individual facility characteristics. Across the 72733 cirrhosis admissions in 805 hospitals, the regression model including clinical risk adjustors, era effects, and facility characteristics explained approximately 15.3% of the total variation in cirrhosis mortality between hospitals. This figure demonstrates the specific hospital factors that additively accounted for this measured variation. Annual cirrhosis volume, case mix, nurse staffing, liver transplant services, and other facility characteristics accounted for this variation, but it is notable that the majority of variation between hospitals remains unexplained.](WJG-23-1857-g002){#F2}

DISCUSSION
==========

Recent data suggest that cirrhosis mortality differs widely across hospitals in the United States. This alarming phenomenon naturally lends itself to questions about what factors within hospitals contribute to this variation. For decades, variation in health care quality has been tied, in part, to differences in structure responsible for health care delivery\[[@B7]\]. In this analysis, we sought to better understand to what extent hospital facility characteristics affect the outcomes of patients admitted with cirrhosis to United States hospitals. Our study demonstrates that several hospital structural domains - case mix, payer mix, staffing patterns, and the presence of specialty liver transplant service line - are predictors of inpatient cirrhosis outcomes, account for a sizable fraction (15%) of the overall variation in mortality.

Recent data have demonstrated that cirrhosis mortality for hospitalized patients has improved over time\[[@B8],[@B9]\], which we also observed in our analysis. While inpatient care in cirrhosis seems to be improving over time overall, nearly 40% of patients with life-threatening cirrhotic complications were admitted to hospitals with higher than expected risk-adjusted mortality rates. Even after adjusting for this era effect, our findings add to a growing body of work that show the importance of specific hospital resources in the care of patients with liver disease, surgical diseases, and malignancy\[[@B6],[@B9]-[@B20]\]. Hospitals with higher than expected risk-adjusted cirrhosis mortality have less resources than those performing better. Resource intensity remains a predictor of survival which is likely driven by the development of care processes based on the local care environment within hospitals.

The specific hospital resources associated with cirrhosis mortality were interesting and speak to a structural footprint for quality cirrhosis care. High cirrhosis volume was significant, and the volume-outcome relationship has long been established in the health services research literature\[[@B15],[@B21],[@B22]\]. In the current study, higher Medicaid payer-mix and higher utilization of LPNs (*vs* RNs) were responsible for a significant portion of the total variation attributable to structural differences. These metrics may be proxies for financial difficulties in resource-strapped facilities that may not have services available that complicated cirrhosis patients require. The presence of a liver transplant program was significant in reducing mortality, but establishing these programs may be a significant hurdle for hospitals and may not be warranted based on current estimates of liver disease mortality nationally. Interestingly, ICU bed capacity, teaching status, and physician staffing were important but not as relevant as the aforementioned factors. This may be related to the near ubiquity of these resources across the population of hospitals in this study. From a clinical perspective, providers understand the ideal structural footprint of a hospital managing advanced cirrhosis- multi-specialty physician staffing, quality nursing, intensive care beds, radiological and endoscopy capacity, and many other services. This notion and some of the findings of this study naturally imply that further capital investments by hospitals may improve clinical outcomes in cirrhosis.

However, boosting resource intensity everywhere is neither the entire solution nor is it financially realistic\[[@B16],[@B17],[@B23]\]. The residual variation in cirrhosis mortality across hospitals remained vast even after accounting for structural differences, implying that unmeasured sources of variation likely account for major differences in clinical performance. By exclusion, based on our conceptual model, this residual variation can be attributable to processes of care and random error. Processes of cirrhosis care were not directly evaluated in this study. Kanwal et al\[[@B16],[@B18],[@B19]\] have outlined usable process of care measures for cirrhosis, but there neither is a national impetus to adopt these, nor is there a platform to track this data on a population level. Based on our findings, it is possible that differences in adherence to quality practices could account for a significant degree of variation. However, since nearly 85% of the variation was attributable to processes of care, care innovation in average and low performing hospitals may demonstrate immediate benefits. Recent initiatives to develop cirrhosis quality improvement programs by the sharing of regional or national data between hospitals holds significant promise, particularly for hospitals with higher than expected mortality.

These findings also have implications for developing care processes beyond the local hospital environment. The hospital characteristic that had the largest effect size in favor of survival was the presence of a liver transplant program. In fact, the beneficial effect of a liver transplant program was observed in non-transplant cases within that facility. In the interest of population health management, our findings imply that liver transplant programs should partner with providers in resource-poor institutions in order to improve care. The development of robust care networks between hospitals may, for example, help expedite transfers of critically ill patients who require liver transplant evaluation, optimize care for those patients who may not be liver transplant candidates, and improve quality of care in cirrhosis in general. There are obvious incentives for creating these networks for both resource-intense and resource-poor institutions, and has been alluded to in centralizing care for other conditions including cancer\[[@B24]-[@B26]\].

Based on our study, resource intensity seems to be responsible for some of this variation, but the totality of differences between hospitals was not completely adjusted for in the analysis. The limitations of this study are related to the inherent nature of the data source - administrative hospital discharge data - which do not adequately capture hospital-specific processes of care in cirrhosis, which are poorly defined in general\[[@B16],[@B18],[@B19]\]. Unmeasured structural variables, unmeasured processes of care, and unmeasured clinical granularity at the patient level may have affected the estimate of mortality risk during a given cirrhosis hospitalization, and so these results have to considered in that context. The statistical approach and study design cannot be used to determine causality, and population-based conclusions can lead to incorrect inferences when applied to individual patient treatments.

Given these limitations, the contribution of resource intensity to hospital variation in cirrhosis mortality is an important consideration for patients, providers, and payers despite secular improvements in inpatient mortality in general. Quality improvement within hospitals and collaboration between centers hold the most promise to address these differences over time.
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